New jab being developed by the Oxford Vaccine Group uses same technology behind the AstraZeneca Covid-19 vaccine British scientists are developing a new Ebola vaccine using the same technology behind the AstraZeneca Covid-19 jab to help fight the outbreak in the Democratic Republic of Congo . The new vaccine is being developed by the Oxford Vaccine Group (OVG) and could be ready for clinical trials within two to three months, its makers say. The outbreak in the DRC involves a rare species of Ebola called Bundibugyo, for which there is no vaccine. It is already one of the biggest outbreaks on record , with 750 suspected cases and 177 deaths. Professor Teresa Lambe, Calleva head of vaccine immunology at the OVG, said: “My hope is that this outbreak can be brought under control quickly and that vaccines are ultimately not needed. “Nevertheless, our team and partners will continue working to ensure that potential vaccine options are available,” she said.…